History of Next Generation Sequencing

NewsGuard 100/100 Score

Next generation sequencing (NGS), often referred to as massively parallel sequencing or deep sequencing, refers to a DNA sequencing technology that enables sequencing of millions of small DNA fragments in unison. This generates a massive pool of data and NGS has revolutionized genomic research studies.

The data created can reach gigabytes in size (the equivalent of 1 billion base pairs of DNA) and using NGS, an entire genome can be sequenced in just one day. By contrast, the previously used Sanger sequencing method, which was used to determine the human genome, took more than ten years to produce the final drafts.

In several ways, discoveries made during the Human Genome Project (HGP) shaped the development of NGS. Reference sequences for the human genome were mainly generated on fluorescent and automated capillary sequencers.

First developed in 1990, capillary sequencing parallelized traditional Sanger sequencing into devices that were able to perform up to 384 reactions simultaneously. The use of radioisotope labels was replaced by fluorescent detection; polyacrylamide slab gels were replaced with polymer-filled capillaries and X-ray film was abandoned in favor of laser fluorescent detection. These developments were made due to the massive sequence capacity that was needed for completion of the human genome.

At the beginning of the twenty-first century, the first drafts of the human genome sequence were completed. Over the following ten years, NGS technologies were developed that could provide high throughput sequencing and produce 20,000 times more data in a single run than the technologies used for the HGP.

Today, sequencing of the HGP era appears low throughput and instead of using numerous capillary sequencers, institutes now run just a few NGS devices instead. The most recent, key article on human genome sequencing that used capillary sequencing was released in 2007 and data that already existed was mainly used. In 2007, more modern technologies started to be used instead.

In 2008, the first paper was published on the production of a human genome sequence (from the DNA of Nobel Laureate James Watson) using NGS. Since then, researchers have published numerous studies of single genomes using a variety of NGS methodologies. More recently, larger scale studies that use NGS for whole genome analysis of patients and families have been performed and the technology has been embraced by cancer experts aiming to characterize tumor types.

In 2015, NGS technologies are now available that enable complete human genomes to be sequenced in just a few days. Coupled to high performance computing and bioinformatics tools for data analysis, individual whole human genome sequences can be created at a cost similar to that of single DNA laboratory tests.

Further Reading

Last Updated: Dec 30, 2022

Sally Robertson

Written by

Sally Robertson

Sally first developed an interest in medical communications when she took on the role of Journal Development Editor for BioMed Central (BMC), after having graduated with a degree in biomedical science from Greenwich University.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Robertson, Sally. (2022, December 30). History of Next Generation Sequencing. News-Medical. Retrieved on April 19, 2024 from https://www.news-medical.net/health/History-of-Next-Generation-Sequencing.aspx.

  • MLA

    Robertson, Sally. "History of Next Generation Sequencing". News-Medical. 19 April 2024. <https://www.news-medical.net/health/History-of-Next-Generation-Sequencing.aspx>.

  • Chicago

    Robertson, Sally. "History of Next Generation Sequencing". News-Medical. https://www.news-medical.net/health/History-of-Next-Generation-Sequencing.aspx. (accessed April 19, 2024).

  • Harvard

    Robertson, Sally. 2022. History of Next Generation Sequencing. News-Medical, viewed 19 April 2024, https://www.news-medical.net/health/History-of-Next-Generation-Sequencing.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Fluent BioSciences awarded NIH SBIR grant to commercialize low-cost million-cell transcriptome profiling kits